backFEATURED ARTICLE
HHS Acting Secretary Fink Issues Memo to Pause Federal Health Communications
On January 21, 2025, according to a memo made available by news outlets, Acting Secretary of HHS, Dr. Dorthy Fink, issued a memo directing the agency’s operating divisions to refrain from most external correspondence, including issuing documents, regulations, guidance, notices, or grant announcements, as well as communications, such as social media, websites, press releases, and communications using listservs, until such material can be approved by “a presidential appointee.” According to the memo, the action is “consistent with precedent” and applies until February 1, 2025. The directive applies to agencies under HHS, including the Food and Drug Administration (FDA), the Centers for Disease Control and Prevention (CDC), the Centers for Medicare and Medicaid Services (CMS), and the National Institutes of Health (NIH). The memo notes that limited exceptions will be made for communications affecting “critical health, safety, environmental, financial or national security functions,” subject to review.
The memo made publicly available by news outlets can be accessed here.
Reporter, Elizabeth Key, Sacramento, +1 916 321 4821, ekey@kslaw.com.
ALSO IN THE NEWS
HHS OIG Grimm Terminated by President Trump
According to news outlets, President Trump removed HHS Inspector General Christi Grimm on January 24, 2025, citing “changing priorities.” Inspector Grimm had led HHS OIG since 2022, and previously served as Principal Deputy Inspector General for the agency. No replacement has been announced.
KING & SPALDING EVENTS
King & Spalding 34th Annual Health Law & Policy Forum
Monday, March 17, 8:00 AM – 5:00 PM ET
The St. Regis Atlanta
Join us for our annual forum focusing on the foremost legal and political developments impacting the healthcare industry.
Health Law & Policy Forum highlights will include:
- Leading practitioners providing policy and regulatory enforcement updates and other industry developments, including insights from in house counsel on their priorities for the coming year
- The future of private equity investment in healthcare, 340B program developments, and how companies and policy makers are responding to a growing trend of "nuclear verdicts" against providers
- What’s in store for healthcare after the 2024 election
Register by March 3, 2025. Registration is available here and is $95 per person.
For questions, contact the K&S Events Team.
Editors: Chris Kenny and Kate Stern
Issue Editors: Elizabeth Key and Dennis Mkrtchian